RNAimmune is Drug Discovery in United States that focus on rare diseases business. Founded in 2020. They cover business area such as Provider, mrna(messenger, acid)-based therapeutic, vaccine, indication, cancer, infectious and rare disease, responsive mechanism, serious infectious disease, unmet need, treatment, viral infection.
2020
( 4 years old in 2024 )
Rare Diseases
-
401 Professional Drive
Suite 280
Gaithersburg, MD 20879
United States
Private
Providermrna(messengeracid)-based therapeuticvaccineindicationcancerinfectious and rare diseaseresponsive mechanismserious infectious diseaseunmet needtreatmentviral infection
* We use standard office opening hours in near RNAimmune's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
RNAimmune is Drug Discovery business from United States that founded in 2020 (4 years old in 2024), RNAimmune business is focusing on Rare Diseases.
RNAimmune headquarter office and corporate office address is located in 401 Professional Drive Suite 280 Gaithersburg, MD 20879 United States.
RNAimmune was founded in United States.
In 2024, RNAimmune is currently focus on rare diseases sector.
Above is snippet of Google Trends for "rare diseases" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with RNAimmune, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
